SGLT inhibition and euglycaemic diabetic ketoacidosis

Lancet Diabetes Endocrinol. 2015 Jul;3(7):503-4. doi: 10.1016/S2213-8587(15)00204-1. Epub 2015 May 27.

Authors

Julia Hine¹, Heather Paterson², Esha Abrol², David Russell-Jones², Roselle Herring²

Affiliations

¹ Cedar Centre, Department of Endocrinology & Diabetes, Royal Surrey County Hospital, Egerton Road, Guildford, GU2 7XX, UK. Electronic address: jhine@doctors.org.uk.
² Cedar Centre, Department of Endocrinology & Diabetes, Royal Surrey County Hospital, Egerton Road, Guildford, GU2 7XX, UK.

PMID: 26025388
DOI: 10.1016/S2213-8587(15)00204-1

No abstract available

Publication types

Letter
Comment

MeSH terms

Diabetes Mellitus, Type 1 / drug therapy*
Humans
Hypoglycemic Agents / adverse effects*
Sodium-Glucose Transport Proteins / antagonists & inhibitors*

Substances

Hypoglycemic Agents
Sodium-Glucose Transport Proteins